Delivery Order SPE2DB24D9803-SPE2DB25FJSNT
- Not listed
- On August 12, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 3, 2025, and no set-aside designation was applied to this award....
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was issued on September 9, 2025, with no set-aside designation applied. The order will be fulfilled from the awardee's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that serves as a critical supplier...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and was awarded on September 3, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on September 9, 2025. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026. The contract requires delivery to Park Ridge, Illinois, with an ultimate completion date of September 30, 2025. No...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract worth $1,126.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the YF-VAX 1 dose vaccine vials, with a period of performance through October 23, 2024. This delivery order contract is part of a larger, single-award indefinite delivery contract (IDC) the DLA has with DMS...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, issued on August 19, 2025, requires performance at the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis within the federal marketplace. DMS Pharmaceutical...
- On September 11, 2025, the Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility with an ultimate completion date of October 2, 2025. The contract employs firm fixed-price pricing with no set-aside designation, allowing the vendor to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on June 26, 2025, for the supply of YF-VAX 1 dose vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois location with an ultimate completion date of July 18, 2025. This award utilizes a firm fixed-price contract type with no set-aside designation, allowing the vendor to compete...
- The Defense Logistics Agency issued a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 16, 2025, and was awarded on August 25, 2025, without any set-aside designation. This delivery order represents an individual procurement action issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and was executed on July 28, 2025. The award was issued without a set-aside designation, leveraging open competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will...
- SPE2DB24D9803Indefinite Delivery Contract
- SPE2DB24D9803-SPE2DB25FJSNTDelivery Order
On September 10, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its facility in Park Ridge, IL, with an ultimate completion date of October 1, 2025. This delivery order was not issued under a set-aside program and represents a routine procurement within the company's existing relationship with DLA. This award is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. Through this DLA SPE2DB program vehicle, the company provides comprehensive pharmaceutical distribution services to military health facilities nationwide, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. YF-VAX vaccine vials represent one of many pharmaceutical products available through this master contract, enabling DLA to issue individual delivery orders as needed to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/10/25 |